Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.685 USD | +3.57% | +2.67% | -8.77% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Financials (USD)
Sales 2024 * | 38.84M | Sales 2025 * | 51.19M | Capitalization | 403M |
---|---|---|---|---|---|
Net income 2024 * | -98M | Net income 2025 * | -106M | EV / Sales 2024 * | 2.23 x |
Net cash position 2024 * | 316M | Net cash position 2025 * | 373M | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-4.13
x | P/E ratio 2025 * |
-4.23
x | Employees | 162 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.71% |
Latest transcript on Voyager Therapeutics, Inc.
1 day | -1.98% | ||
1 week | -1.72% | ||
Current month | -20.30% | ||
1 month | -19.87% | ||
3 months | -2.50% | ||
6 months | +10.09% | ||
Current year | -12.09% |
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 7.69 | +3.64% | 143 783 |
24-04-25 | 7.42 | -1.98% | 522,452 |
24-04-24 | 7.57 | -1.05% | 312,899 |
24-04-23 | 7.65 | +1.06% | 372,355 |
24-04-22 | 7.57 | +0.93% | 324,119 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.09% | 403M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.96% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- VYGR Stock